ICD-10-CM Billable Code

C44.122

Squamous cell carcinoma of skin of right eyelid, including canthus

Clinical Classification Guidelines

Medical Intelligence & Overview

Squamous cell carcinoma of the skin of the right eyelid, including the canthus, is a form of skin cancer that originates in the squamous cells, which are flat cells located in the outermost layer of the skin. This type of cancer can develop when abnormal cells grow uncontrollably, often as a result of prolonged exposure to ultraviolet (UV) radiation from the sun or tanning beds. Recognized under the ICD-10 code C44.122, it primarily affects individuals with cumulative sun exposure or prior skin damage, and early detection is crucial for effective management and treatment.

Causes & Symptoms

Clinical Causes: Chronic exposure to ultraviolet (UV) radiation from sunlight or tanning beds History of sunburns or extensive sun exposure over time Presence of pre-existing skin conditions or lesions that may predispose to cancer Fair skin, light hair, and light eye color, which are more susceptible Ageing, as the risk increases with advancing age Exposure to certain chemical carcinogens Immunosuppression due to medical conditions or medications

Key Symptoms: A persistent, non-healing sore or ulcer on the eyelid A raised, firm, or scaly lesion that may resemble a wart or scaly patch Redness or swelling around the affected area A bump or nodule that may be keratotic or crusted Changes in skin color, such as yellow or brown pigmentation Loss of eyelashes or changes in eyelid appearance Discomfort or itching in the affected area In advanced cases, invasion into surrounding tissues causing eyelid deformity

Diagnostic & Treatment

Diagnosis Path: Diagnosis typically involves a thorough medical history and physical examination of the eyelid area. A dermatologist may perform skin biopsies, where a small sample of tissue is removed and analyzed microscopically to confirm the presence of cancer cells. Imaging studies, such as ultrasound or MRI, might be used to assess the extent of local invasion or involvement of surrounding structures. Early detection relies on recognizing suspicious lesions, especially in individuals with significant sun exposure or risk factors.

Treatment Protocols: Treatment options for squamous cell carcinoma of the eyelid include various surgical and non-surgical approaches, tailored to the tumor's size, location, and spread. Common treatment modalities are: - **Surgical excision:** Removal of the tumor with a margin of healthy tissue, often performed via Mohs micrographic surgery to preserve as much healthy tissue as possible. - **Cryotherapy:** Freezing cancerous cells with liquid nitrogen, typically used for small or superficial lesions. - **Radiation therapy:** Used when surgery isn't feasible or as an adjunct to surgical removal. - **Topical therapies:** Such as chemotherapeutic agents or immunomodulators, mainly for superficial lesions. - **Reconstruction:** After tumor removal, reconstructive procedures may be necessary to restore eyelid functionality and appearance. Follow-up care involves regular monitoring to detect any recurrence or new lesions, emphasizing the importance of ongoing skin protection measures.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C44.122 a billable ICD-10 code?
Yes, C44.122 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C44.122?
Clinical documentation must specify the nature of Squamous cell carcinoma of skin of right eyelid, including canthus and any associated comorbidities for accurate reporting.

Cite this Clinical Reference